Skip to main content
. 2020 Apr 30;106(15):1154–1159. doi: 10.1136/heartjnl-2020-317007

Table 4.

Predictors of progression to severe disease

Univariate
OR (95% CI) P value
Age 1.07 (1.04 to 1.1) <0.001
Males 1.47 (0.3 to 1.54) 0.357
Hypertension 5.36 (1.91 to 15.04) 0.001
Diabetes mellitus 2.76 (0.88 to 8.69) 0.083
Cerebrovascular disease 10.16 (1.14 to 90.6) 0.038
Smoking 3.28 (0.74 to 14.61) 0.119
Use of ACEi/ARB 2.82 (0.45 to 17.72) 0.268
Use of CCB 4.28 (1.19 to 15.36) 0.026
WBC 1.07 (0.93 to 1.24) 0.334
CRP 1.02 (1.01 to 1.04) 0.003
eGFR 0.97 (0.95 to 0.99) 0.001
Log NT-proBNP 2.80 (1.74 to 4.52) <0.001
Log hs-TnT 6.63 (2.24 to 19.65) 0.001
Pulmonary lesion ratio 1.10 (1.07 to 1.15) <0.001

ACEi, ACE inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium channel blocker; CRP, C reactive protein; eGFR, estimated glomerular filtration rate; hs-TnT, high-sensitivity troponin T; NT-proBNP, N-terminal-proB-type natriuretic peptide; WBC, white blood cell count.